In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page

Changes in formulation and content of several codes from ‘The guidelines of the inspection board’ in the Netherlands

by In2Pharma | Jan 28, 2019 | News

The Netherlands After revision of the code for public advertising and medical self-care tools (CPMH), the code for the promotion of health products (CAG) and the code for advertising of medicines (CPG), various adjustments were made: To make the codes more...

Prohibition of medical claims for health products also applies to (specific combinations of) ingredients

by In2Pharma | May 23, 2018 | News

The Netherlands It is forbidden to make medical claims for healthcare products that are not registered as medicines such as food supplements. Only claims that are approved by European Food Safety Authority (EFSA), including ‘on hold’ claims for botanicals, can be...

Recent Posts

  • Update Procedure for MA applications in Luxembourg
  • Labeling Medicinal products
  • New clarification about Day 0 in local literature search published by EMA
  • Revision IML Code of Ethics
  • CBG starts authorizing temporarily different packaging

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België